ArticleCureus2024

Safety Study and Compositional Analysis of the Svarnvir-IV Tablet With Special Reference to Its Therapeutic Utility in SARS-CoV-2.

K Ramachandra Reddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.